SCHEMBL8229259

SCHEMBL8229259

CCCC(=O)N1CCN(C2CCCCC2)CC1

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
KMT2A Q03164 4/20 0.56
TSHR P16473 1/20 0.56
HRH3 Q9Y5N1 5/20 0.53
LMNA P02545 1/20 0.52
KDM4E B2RXH2 2/20 0.51
POLB P06746 2/20 0.51
MAPT P10636 1/20 0.51
MEN1 O00255 2/20 0.51
HSD17B10 Q99714 1/20 0.50
PHGDH O43175 1/20 0.50
MGLL Q99685 1/20 0.50
HSD11B1 P28845 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13453030 0.86 EPHX2 (0.54) ALDH1A1KMT2ATSHRHRH3LMNA
SCHEMBL19773151 0.86 EPHX2 (0.54) ALDH1A1KMT2ATSHRHRH3LMNA
SCHEMBL24204794 0.85 GNAI3 (0.51) ALDH1A1KMT2ATSHRHRH3POLB
SCHEMBL14614943 0.84 MEN1 (0.59) ALDH1A1KMT2AKDM4EMEN1
SCHEMBL14035661 0.84 ALDH1A1 (0.55) ALDH1A1KMT2ATSHRHRH3LMNA
SCHEMBL11490502 0.83 GNAI3 (0.51) ALDH1A1KMT2ATSHRHRH3KDM4E
SCHEMBL24206641 0.83 ACACB (0.43) ALDH1A1KMT2ATSHRHRH3MEN1
SCHEMBL24204480 0.83 GNAI3 (0.51) ALDH1A1KMT2ATSHRHRH3LMNA
SCHEMBL3766758 0.81 CHRNB2 (0.47) ALDH1A1KMT2AHRH3LMNAKDM4E
SCHEMBL22672734 0.80 HRH3 (0.51) ALDH1A1KMT2ATSHRHRH3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4153209-A1 METHOD FOR TREATING LYSOSOMAL STORAGE DISEASES WITH HISTATIN PEPTIDES The Board of Trustees of the University of Illinois (US) 2023-03-29 EP disclosed
WO-2007109615-A2 β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS AZEVAN PHARMACEUTICALS, INC. (US) 2007-09-27 WO disclosed